Breast Cancer Screening and Diagnosis, NCCN clinical practice guidelines in oncology – Breast Cancer Screening and Diagnosis
https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdfColorectal Cancer Screening, NCCN clinical practice guidelines in oncology – Colorectal Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdfLung Cancer Screening, NCCN clinical practice guidelines in oncology – Lung Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdfNCCN Guidelines Colorectal Cancer Screening, NCCN clinical practice guidelines in oncology – Colorectal Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/colorectal_screening.pdfNCCN Guidelines Lung Cancer Screening, NCCN clinical practice guidelines in oncology – Lung Cancer Screening
https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdfNCCN Guidelines Breast Cancer Screening and Diagnosis, NCCN clinical practice guidelines in oncology – Breast Cancer Screening and Diagnosis
https://www.nccn.org/professionals/physician_gls/pdf/breast-screening.pdfNCCN Guidelines for Patients Breast Cancer Screening and Diagnosis, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Breast Cancer Screening and Diagnosis
https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdfNCCN Guidelines for Patients Colorectal Cancer Screening, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Colorectal Cancer Screening
https://www.nccn.org/patients/guidelines/content/PDF/colorectal-screening-patient.pdfNCCN Guidelines for Patients Lung Cancer Screening, These NCCN Guidelines for Patients® are based on the NCCN Clinical Practice Guidelines in Oncology. (NCCN Guidelines®) for – Lung Cancer Screening
https://www.nccn.org/patients/guidelines/content/PDF/lung_screening-patient.pdfResume Screening, ) Breast Cancer Risk Reduction Breast Cancer Screening and Diagnosis Colorectal Cancer Screening, Assessment: Colorectal, Endometrial, and Gastric Lung Cancer Screening Prostate Cancer Early, Cancer Breast Cancer Screening and Diagnosis Cervical Cancer Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Colon Cancer Colorectal Cancer Screening Cutaneous B-Cell Lymphomas Cutaneous T, Kidney Cancer Liver Cancer Lung Cancer Screening Mantle Cell Lymphoma Marginal Zone Lymphomas
https://www.nccn.org/covid-19/resume-screeningPatient Webinar Breast Cancer Screening, for those interested in learning more about Breast Cancer Screening. Experts discussed how to understand the purpose of breast cancer screening and the options for those at average risk, factors, : Discuss breast cancer screening and breast cancer risk with your health care provider(s). The most recent Patient Webinar: Breast Cancer Screening occurred in February 2024. This informational program was created in conjunction with the NCCN Guidelines for Patients®: Breast Cancer Screening
https://www.nccn.org/patientresources/patient-resources/patient-webinars/patient-webinar-breast-cancer-screeningDownload a printable flyer about the Breast Cancer Screening webinar to share with others!, Tuesday, February 27, 2024 • 3:00 – 4:15 pm EST Free Patient Webinar Breast Cancer Screening Join the experts As they discuss breast cancer screening. This webinar is designed to help participants: • Understand the purpose of breast cancer screening and the options for those at average, in shared decision-making: Discuss breast cancer screening and breast cancer risk with your health care provider(s). Agenda • Introduction • Expert discussion of Breast Cancer Screening • Question
https://www.nccn.org/docs/default-source/patient-resources/webinar-flyer/download-a-printable-flyer-about-the-breast-cancer-screening-webinar-to-share-with-others!.pdf?sfvrsn=615a868f_4General Survivorship Principles: Screening for Subsequent New Primary Cancers
https://www.nccn.org/professionals/physician_gls/pdf/survivorship.pdfNCCN's Response to the United States Preventive Services Task Force (USPSTF) Draft Recommendation Statement on Screening for Breast Cancer
https://www.nccn.org/docs/default-source/oncology-policy-program/access/nccn-final-response-uspstf-breast-cancer-screening.pdf?sfvrsn=818ca135_3NCCN's Response to the Center for Medicare and Medicaid Services (CMS) Development of an Electronic Clinical Quality Measure (eCQM) to Evaluate Hospitals on Social Needs Screening and Follow Up for Patients
https://www.nccn.org/docs/default-source/oncology-policy-program/equity/nccn-comment-letter-on-ecqm.pdf?sfvrsn=e5647c81_5. Distress Thermometer Screening Tool Translation Distress Thermometer Screening Tool Version 2.2022 (Afrikaans) Distress Thermometer Screening Tool Version 2.2022 (Albanian) Distress Thermometer Screening Tool Version 2.2022 (Amharic) Distress Thermometer Screening Tool Version 2.2022 (Arabic) Distress Thermometer Screening Tool Version 2.2022 (Armenian) Distress Thermometer Screening Tool Version 2.2022 (Bengali/Bangla
https://www.nccn.org/global/what-we-do/distress-thermometer-tool-translationsas documented through the medical record or meeting notes. Offers flexible hours for screening and treatment, of the Human Papillomavirus(HPV) vaccine. Supporting Access to Screening: Congress should allocate additional funding for CDC screening programs including the National Breast and Cervical Cancer Early, allocate funds for screening that prioritizes cancers where disparities are particularly prevalent. Supporting Access to Screening: Congress should allocate funds to be granted to community-based
https://www.nccn.org/docs/default-source/oncology-policy-program/equity/nccn-response-cms-interoperability-and-prior-authorization-processes.pdf?sfvrsn=cb921fb8_3as documented through the medical record or meeting notes. Offers flexible hours for screening and treatment, of the Human Papillomavirus(HPV) vaccine. Supporting Access to Screening: Congress should allocate additional funding for CDC screening programs including the National Breast and Cervical Cancer Early, allocate funds for screening that prioritizes cancers where disparities are particularly prevalent. Supporting Access to Screening: Congress should allocate funds to be granted to community-based
https://www.nccn.org/docs/default-source/oncology-policy-program/guidelines/nccn-response-cms-interoperability-and-prior-authorization-processes.pdf?sfvrsn=f0190b3d_5should be based on the best available evidence for prevention, screening, diagnosis, treatment, Practice Guidelines, and the American Cancer Society Guidelines for Cancer Screening and Prevention, Resources for Cancer Care (2020 Standards) Ensure access to preventive screening, genetic testing, and genomic testing. Ensure access to evidence-based cancer screenings, evidence-based genetic, -to-date information for age appropriate screenings and surveillance. Require carriers to utilize NCCN
https://www.nccn.org/business-policy/business/employer-resources/employer-toolkit, health systems have begun initiatives to improve health system screening for Health-Related Social, i o n s to integrate HRSN screening. The Healthy People 2030 Initiative by the Department of Health, for Medicare and Medicaid Services (CMS) has proposed implementation of the quality measures “Screening, Thermometer and Problem List, the PRAPA R E Screening Tool ® , and the Accountable Health Communities Screening Tool. A number of states have also taken steps to address the needs of Medicaid
https://www.nccn.org/docs/default-source/oncology-policy-program/hrsn-wg-recommendations.pdf?sfvrsn=444faf60_4